rs281865500
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004614.5(TK2):c.129_132delAGAA(p.Lys43AsnfsTer9) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,338 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. K43K) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004614.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mitochondrial DNA depletion syndrome, myopathic formInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- autosomal recessive progressive external ophthalmoplegiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TK2 | NM_004614.5 | c.129_132delAGAA | p.Lys43AsnfsTer9 | frameshift_variant | Exon 2 of 10 | ENST00000544898.6 | NP_004605.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TK2 | ENST00000544898.6 | c.129_132delAGAA | p.Lys43AsnfsTer9 | frameshift_variant | Exon 2 of 10 | 1 | NM_004614.5 | ENSP00000440898.2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151950Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461388Hom.: 0 AF XY: 0.00000413 AC XY: 3AN XY: 727006 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151950Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74202 show subpopulations
ClinVar
Submissions by phenotype
Mitochondrial DNA depletion syndrome, myopathic form Pathogenic:2
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with mitochondrial DNA depletion syndrome 2 (myopathic type) (MIM#609560). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0115 - Variants in this gene are known to have variable expressivity (OMIM, GeneReviews). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v3) <0.01 for a recessive condition (1 heterozygote, 0 homozygotes). (SP) 0701 - Other null variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. There are at least five NMD-predicted variants that have been classified as likely pathogenic or pathogenic (ClinVar, DECIPHER). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. This variant has been reported in a child with mitochondrial depletion syndrome and is compound heterozygous with a second missense variant in TK2 (PMID: 23932787). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
ACMG codes:PVS1, PM2, PM3 -
not provided Pathogenic:2
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32573669, 29602790, 34930662, 23932787, 19736010) -
This sequence change creates a premature translational stop signal (p.Lys43Asnfs*9) in the TK2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TK2 are known to be pathogenic (PMID: 20421844). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 38973). This variant is also known as c.255_c.258delAGAA (p.K85NfsX9). This premature translational stop signal has been observed in individual(s) with mitochondrial DNA depletion syndrome (PMID: 19736010). This variant is present in population databases (rs281865500, gnomAD 0.0009%). -
Mitochondrial disease Pathogenic:1
TK2 p.Lys43AsnfsTer9 (c.129_132del) is a frameshift variant that results in the production of a truncated protein which is predicted to have a deleterious effect on TK2 gene function. It is also described as K85NfsX9 in the literature. This variant has been observed in a proband affected with mitochondrial disease in the compound heterozygous state (PMID:19736010). This variant is not present at a significant frequency in gnomAD. In conclusion, we classify TK2 p.Lys43AsnfsTer9 (c.129_132del) as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at